Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

91 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Messenger RNA therapy for rare genetic metabolic diseases.
Berraondo P, Martini PGV, Avila MA, Fontanellas A. Berraondo P, et al. Among authors: fontanellas a. Gut. 2019 Jul;68(7):1323-1330. doi: 10.1136/gutjnl-2019-318269. Epub 2019 Feb 22. Gut. 2019. PMID: 30796097 Review.
Epidermal growth factor receptor ligands in murine models for erythropoietic protoporphyria: potential novel players in the progression of liver injury.
Berasain C, Sampedro A, Mauleón I, Goñi S, Latasa MU, Matscheko N, García-Bravo M, Unzu C, Corrales FJ, Enríquez de Salamanca R, Prieto J, Avila MA, Fontanellas A. Berasain C, et al. Among authors: fontanellas a. Cell Mol Biol (Noisy-le-grand). 2009 Feb 16;55(1):29-37. Cell Mol Biol (Noisy-le-grand). 2009. PMID: 19267999
Effect of adeno-associated virus serotype and genomic structure on liver transduction and biodistribution in mice of both genders.
Pañeda A, Vanrell L, Mauleon I, Crettaz JS, Berraondo P, Timmermans EJ, Beattie SG, Twisk J, van Deventer S, Prieto J, Fontanellas A, Rodriguez-Pena MS, Gonzalez-Aseguinolaza G. Pañeda A, et al. Among authors: fontanellas a. Hum Gene Ther. 2009 Aug;20(8):908-17. doi: 10.1089/hum.2009.031. Hum Gene Ther. 2009. PMID: 19419275
Emerging therapies for acute intermittent porphyria.
Fontanellas A, Ávila MA, Berraondo P. Fontanellas A, et al. Expert Rev Mol Med. 2016 Nov 2;18:e17. doi: 10.1017/erm.2016.18. Expert Rev Mol Med. 2016. PMID: 27804912 Review.
Systemic messenger RNA as an etiological treatment for acute intermittent porphyria.
Jiang L, Berraondo P, Jericó D, Guey LT, Sampedro A, Frassetto A, Benenato KE, Burke K, Santamaría E, Alegre M, Pejenaute Á, Kalariya M, Butcher W, Park JS, Zhu X, Sabnis S, Kumarasinghe ES, Salerno T, Kenney M, Lukacs CM, Ávila MA, Martini PGV, Fontanellas A. Jiang L, et al. Among authors: fontanellas a. Nat Med. 2018 Dec;24(12):1899-1909. doi: 10.1038/s41591-018-0199-z. Epub 2018 Oct 8. Nat Med. 2018. PMID: 30297912
Heme oxygenase-1 inducer hemin does not inhibit SARS-CoV-2 virus infection.
Maestro S, Córdoba KM, Olague C, Argemi J, Ávila MA, González-Aseguinolaza G, Smerdou C, Fontanellas A. Maestro S, et al. Among authors: fontanellas a. Biomed Pharmacother. 2021 May;137:111384. doi: 10.1016/j.biopha.2021.111384. Epub 2021 Feb 13. Biomed Pharmacother. 2021. PMID: 33761605 Free PMC article.
91 results